WSCM
PPH icon

Wellington Shields Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wellington Shields Capital Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,000
Closed -$311K – 321
2023
Q1 		$311K Hold
4,000
– – 0.04% 189
2022
Q4 		$311K Hold
4,000
– – 0.04% 189
2022
Q3 		$269K Buy
+4,000
New +$295K 0.06% 195

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
VAS
Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Wellington Shields Capital Management's PPH Position: Q2 2023 in Review

Wellington Shields Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 4,000 shares — an estimated $311K sold.

Wellington Shields Capital Management first reported a position in PPH in Q3 2022 and held it in 3 quarters. The position peaked at $311K in Q4 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

  • Wellington Shields Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
  • Wellington Shields Capital Management sold 4,000 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $311K.
  • Wellington Shields Capital Management first reported a position in VanEck Pharmaceutical ETF in Q3 2022 and held it in 3 quarters.
  • Wellington Shields Capital Management's VanEck Pharmaceutical ETF position peaked at $311K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on Wellington Shields Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.